首页 >
法规速递
-
Document: Pilot participation letter: Clinical study data proof-of-concept-2025/7/7
2025-07-08查看详情 > -
Document: Composition of the Emergency Task Force (ETF) for preparedness-2025/8/7
2025-08-10查看详情 > -
国家药监局综合司公开征求《关于特定情形实施医疗器械唯一标识有关事项的公告（征求意见稿）》 《关于做好后续品种实施医疗器械唯一标识工作的公告（征求意见稿）》意见-2025/9/25
2025-09-26查看详情 > -
Document: Advice to medical device manufacturers - 2026 Timetable-2025/11/3
2025-11-04查看详情 > -
Page: Network Data Steering Group (NDSG)-2025/12/3
2025-12-04查看详情 > -
Page: Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) meetings-2026/1/6
2026-01-07查看详情 > -
Document: PhV non-compliance notification contact points at National Competent Authority (NCA) level-2026/2/10
2026-02-11查看详情 > -
Document: Article 57 product data-2026/3/19
2026-03-20查看详情 > -
国家药监局关于25批次化妆品检出禁用原料的通告（2026年第14号）-2026/4/24
2026-04-27查看详情 > -
国家药监局关于废止《心血管植入物 人工心脏瓣膜 第3部分：经导管植入式人工心脏瓣膜》等10项医疗器械行业标准的公告（2026年第56号）-2026/6/5
2026-06-08查看详情 >
